市場調查報告書

細胞化驗分析的全球市場:市場機會分析及未來預測

Global Cell-based Assay Market Size study, by Product & Service, Application, End-user and Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 909738
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
細胞化驗分析的全球市場:市場機會分析及未來預測 Global Cell-based Assay Market Size study, by Product & Service, Application, End-user and Regional Forecasts 2019-2026
出版日期: 2019年04月01日內容資訊: 英文
簡介

本報告提供全球細胞化驗分析市場調查,整體市場趨勢,各市場區隔詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等資訊總括性彙整。

目錄

第1章 摘要整理

  • 市場概述
  • 主要趨勢
  • 全球的及各分類市場預測
    • 各產品及服務
    • 各應用領域
    • 各終端用戶
    • 各地區
  • 預測方法
  • 調查的前提條件

第2章 市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 產業的演進
    • 調查範圍
  • 調查對象期間
  • 貨幣換算比率

第3章 市場動態

  • Seesaw分析
    • 市場成長要素
    • 市場課題
    • 市場機會

第4章 產業分析

  • 波特的5力模式
    • 買主談判力
    • 供應商談判力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 競爭對手
    • 波特的5力模式的未來方法
  • PEST分析
    • 政治方案
    • 經濟方案
    • 社會方案
    • 技術方案
  • 主要的購買標準(按需)
  • 法律規範(按需)
  • 投資/引進方案(按需)
  • 分析師的建議與結論

第5章 各產品、服務市場

  • 市場概述
  • 市場效能-潛在模式
  • 子區隔分析
    • 消耗品
    • 器具
    • 服務

第6章 各應用領域市場

  • 市場概述
  • 市場效能-潛在模式
  • 子區隔分析
    • 藥物研發
    • 基礎研究
    • 其他

第7章 各終端用戶市場

  • 市場概述
  • 市場效能-潛在模式
  • 子區隔分析
    • 製藥、生物科技企業
    • 學術機構及政府機關
    • 受託研究機構

第8章 各地區市場

  • 地區市場概述
  • 北美市場概述
    • 美國
    • 加拿大
  • 歐洲市場概述
    • 英國
    • 其他
  • 亞太地區市場概述
    • 中國
    • 印度
    • 日本
    • 其他
  • 中南美市場概述
    • 巴西
    • 墨西哥
  • 其他地區
    • 中東、非洲地區

第9章 競爭資訊

  • 企業的市場佔有率
  • 最尖端市場策略
  • 企業概要
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Becton, Dickinson and Company
    • Ge Healthcare
    • Merck KGaA
    • Lonza Group Ltd.
    • Perkinelmer, Inc.
    • Charles River Laboratories, Inc.
    • Cell Signaling Technology, Inc.
    • Promega Corporation

第10章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
    • 調查的前提條件
目錄

Global Cell-based Assay Market is valued approximately USD 13.10 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.30% over the forecast period 2019-2026. Cell based assay refers to a technique of analysis of living cell on the basis of various parameters. In cell-based assays, functional cells are used as diagnostic tools in research for new drugs. Also, cell-based assays help to measure cell motility, proliferations and facilitate research in the area of stem cells, immunology, cancer and others. Further, rising prevalence of chronic diseases and lifestyle disorders and rising adoption of high-throughput screening methods have led to the adoption of Cell-based Assay across the forecast period. According to fight chronic disease organization in 2015, in US 133 million deaths are caused and disability due to chronic diseases. It is estimated that 45% Americans populations are suffering from at least one chronic disease. Also, with the increasing investments in research and development for drug discovery, the adoption & demand for Cell-based Assay is likely to increase. However, high maintenance and operational costs impedes the growth of the market over the forecast period of 2019-2026.

The regional analysis of global Cell-based Assay market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the well-established healthcare sector along with the high adoption of cell-based therapies. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as technological advancement, rise in investments in R&D includes life science research and drug discover outsourcing would create lucrative growth prospects for the Cell-based Assay market across Asia-Pacific region.

Major market player included in this report are:

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • GE Healthcare
  • Merck KGaA
  • Lonza Group Ltd.
  • Perkinelmer, Inc.
  • Charles River Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Promega Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product & Services:

  • Consumables
  • Instruments
  • Services
  • By Application:

  • Drug Discovery
  • Basic Research
  • Other Applications

By End-user:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Government Institutes
  • Contract Research Organizations

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2016, 2017
  • Base year - 2018
  • Forecast period - 2019 to 2026

Target Audience of the Global Cell-based Assay Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
    • 1.3.1. Cell-based Assay Market, by Product & Services, 2016-2026 (USD Billion)
    • 1.3.2. Cell-based Assay Market, by Application, 2016-2026 (USD Billion)
    • 1.3.3. Cell-based Assay Market, by End-user, 2016-2026 (USD Billion)
    • 1.3.4. Cell-based Assay Market, by Region, 2016-2026 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cell-based Assay Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cell-based Assay Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Cell-based Assay Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria (On Demand)
  • 4.4. Regulatory Framework (On Demand)
  • 4.5. Investment Vs Adoption Scenario (On Demand)
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Global Cell-based Assay Market, by Product & Service

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Cell-based Assay Market, Sub Segment Analysis
    • 5.3.1. Consumables
      • 5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.3.2. Instruments
      • 5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.3.3. Services
      • 5.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6. Global Cell-based Assay Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Cell-based Assay Market, Sub Segment Analysis
    • 6.3.1. Drug Discovery
      • 6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.3.2. Basic Research
      • 6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.3.3. Other Applications
      • 6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7. Global Cell-based Assay Market, by End User

  • 7.1. Market Snapshot
  • 7.2. Market Performance - Potential Model
  • 7.3. Cell-based Assay Market, Sub Segment Analysis
    • 7.3.1. Pharmaceutical & Biotechnology Companies
      • 7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.3.2. Academic & Government Institutes
      • 7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.3.3. Contract Research Organizations
      • 7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8. Global Cell-based Assay Market, by Regional Analysis

  • 8.1. Cell-based Assay Market, Regional Market Snapshot (2016-2026)
  • 8.2. North America Cell-based Assay Market Snapshot
    • 8.2.1. U.S.
      • 8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.2. Product & Service breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.2.2. Canada
      • 8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.2. Product & Service breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.3. Europe Cell-based Assay Market Snapshot
    • 8.3.1. U.K.
      • 8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.2. Product & Service breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.3.2. Rest of Europe
      • 8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.2. Product & Service breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.4. Asia Pacific Cell-based Assay Market Snapshot
    • 8.4.1. China
      • 8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.2. Product & Service breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.2. India
      • 8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.2. Product & Service breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.3. Japan
      • 8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.2. Product & Service breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.4. Rest of Asia Pacific
      • 8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.2. Product & Service breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.5. Latin America Cell-based Assay Market Snapshot
    • 8.5.1. Brazil
      • 8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.2. Product & Service breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.5.2. Mexico
      • 8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.2. Product & Service breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.6. Rest of The World
    • 8.6.1. Middle East and Africa
      • 8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.2. Product & Service breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 9. Competitive Intelligence

  • 9.1. Company Market Share (Subject to Data Availability)
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Thermo Fisher Scientific Inc.
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial (Subject to Data Availability)
      • 9.3.1.3. Product Summary
      • 9.3.1.4. Recent Developments
    • 9.3.2. Danaher Corporation
    • 9.3.3. Becton, Dickinson and Company
    • 9.3.4. Ge Healthcare
    • 9.3.5. Merck KGaA
    • 9.3.6. Lonza Group Ltd.
    • 9.3.7. Perkinelmer, Inc.
    • 9.3.8. Charles River Laboratories, Inc.
    • 9.3.9. Cell Signaling Technology, Inc.
    • 9.3.10. Promega Corporation

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
    • 10.1.6. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CELL-BASED ASSAY MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CELL-BASED ASSAY MARKET
  • TABLE 3. GLOBAL CELL-BASED ASSAY MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. GLOBAL CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY PRODUCT & SERVICE 2016-2026 (USD BILLION)
  • TABLE 8. GLOBAL CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
  • TABLE 9. GLOBAL CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
  • TABLE 10. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. GLOBAL CELL-BASED ASSAY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. GLOBAL CELL-BASED ASSAY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. GLOBAL CELL-BASED ASSAY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. GLOBAL CELL-BASED ASSAY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. GLOBAL CELL-BASED ASSAY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. GLOBAL CELL-BASED ASSAY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. GLOBAL CELL-BASED ASSAY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. GLOBAL CELL-BASED ASSAY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. GLOBAL CELL-BASED ASSAY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 28. U.S. CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. U.S. CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 30. U.S. CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 31. U.S. CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 32. CANADA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. CANADA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 34. CANADA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 35. CANADA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 36. UK CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 37. UK CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 38. UK CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 39. UK CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 40. GERMANY CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. GERMANY CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 42. GERMANY CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 43. GERMANY CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 44. ROE CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. ROE CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 46. ROE CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 47. ROE CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. CHINA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 49. CHINA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. CHINA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. CHINA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. INDIA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 53. INDIA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. INDIA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. INDIA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. JAPAN CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 57. JAPAN CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. JAPAN CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 59. JAPAN CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60. ROAPAC CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 61. ROAPAC CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 62. ROAPAC CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 63. ROAPAC CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 64. BRAZIL CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 65. BRAZIL CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 66. BRAZIL CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION).
  • TABLE 67. BRAZIL CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 68. MEXICO CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 69. MEXICO CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 70. MEXICO CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 71. MEXICO CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 72. ROLA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 73. ROLA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 74. ROLA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 75. ROLA CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 76. ROW CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 77. ROW CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 78. ROW CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 79. ROW CELL-BASED ASSAY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. GLOBAL CELL-BASED ASSAY MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL CELL-BASED ASSAY MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL CELL-BASED ASSAY MARKET, KEY TRENDS 2017
  • FIG 5. GLOBAL CELL-BASED ASSAY MARKET, GROWTH PROSPECTS 2018-2026
  • FIG 6. GLOBAL CELL-BASED ASSAY MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL CELL-BASED ASSAY MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL CELL-BASED ASSAY MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 15. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 16. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 17. GLOBAL CELL-BASED ASSAY MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 18. GLOBAL CELL-BASED ASSAY MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 19. NORTH AMERICA CELL-BASED ASSAY MARKET 2016 & 2026 (USD BILLION)
  • FIG 20. EUROPE CELL-BASED ASSAY MARKET 2016 & 2026 (USD BILLION)
  • FIG 21. ASIA PACIFIC CELL-BASED ASSAY MARKET 2016 & 2026 (USD BILLION)
  • FIG 22. LATIN AMERICA CELL-BASED ASSAY MARKET 2016 & 2026 (USD BILLION)
  • FIG 23. GLOBAL CELL-BASED ASSAY MARKET, COMPANY MARKET SHARE ANALYSIS (2017)